The cortical and medullary thymic epithelial cell (cTEC and mTEC) lineages are essential for 1 9 3 1 3
4 0
Flow cytometry confirmed the reduction in the number and frequency of mTECs in the 1 4 1 Foxn1 Cre ;Notch1 fx/fx mutant thymus at E17.5 (P < 0.05; Fig. 3I ).
4 2
As total TEC numbers were similar in control and Foxn1 Cre ;Notch1 fx/fx mutants (P = 1 4 3 0.32), the reduction in mTEC frequency was correlated with a relative increase in cTECs. The 1 4 4 relative cTEC frequency was significantly increased (controls, 84.26 +/-1.65; mutants, 93.71 +/-1 4 5 1.11; p= 0.0001), although cTEC numbers were not significantly different (P = 0.27). The cTEC 1 4 6 markers β5t and CD205 expression appeared normal at E16.5 ( Fig. 3E-H) . Therefore, the 1 4 7 primary defect in TEC based on this analysis was in the mTEC lineage. co-express these markers are thought to contain a progenitor population, and are normally 1 7 2 located at the cortico-medullary junction 22 . In the control E14.5 thymus, proto-medullary areas 1 7 3 were beginning to down regulate K8 in the center surrounded by a band of K8 + K5 + cells, while 1 7 4 the remainder of TEC were K5 negative, delineating the emerging cortical and medullary regions 1 7 5 ( Fig. 4A-C) . However, in the Foxn1 Cre ;Rosa N1-IC thymus at the same stage, almost all TECs were 1 7 6 K8 + K5 + , with only a few single K8 + cells (Fig. 4D-F and inset) . Furthermore, both PLET1 and 1 7 7 CLD3,4 positive cells were expanded in the Foxn1 Cre ;Rosa N1-IC thymus at E15.5 ( Fig. 4G-N ). Although PLET1 and CLD3,4 single positive cells were present in the Foxn1 Cre ;Rosa N1-IC 1 7 9 thymus, most of these cells expressed both markers. Flow cytometry at E15.5 showed about a 4-1 8 0 fold expansion in the frequency of CLD3 + cells in the Foxn1 Cre ;Rosa N1-IC mutant thymus 1 8 1 compared to littermate controls (P < 0.05; Fig. 4O ), and the number of CLD3 + cells more than 1 8 2 doubled in the mutant (an average of 1233 (SD = 387.1), versus 496 (SD = 50.1) cells in the 1 8 3 controls (n = 3; P = 0.03). Total TEC cellularity was not different between mutant and control at 1 8 4 this stage (P = 0.32). Flow cytometry for UEA1 also revealed a dramatic expansion of the 1 8 5 1 9 8 differentiation, ultimately leading to a complete collapse of the TEC network. In contrast to the loss-of-function models, thymocyte development was affected by the 2 0 0 abnormal TEC microenvironment in the Foxn1 Cre ;Rosa N1-IC mice. The strongest effect was on 2 0 1 total thymocyte numbers, which were reduced in the Foxn1 Cre ;Rosa N1-IC thymus, with an average 2 0 2 of 1.9x10 6 thymocytes (SD = 0.51) in the mutant thymus compared with 12.5x10 6 (SD = 2.12) in 2 0 3 the control (P = 0.002). However, thymocyte differentiation was only mildly affected. Flow 2 0 4 cytometry analysis of E16.5 Foxn1 Cre ;Rosa N1-IC thymocytes revealed a slightly lower percentage 2 0 5 of CD4 + 8 + cells (Fig. 5K ), and an increase in DN3 (CD44 -CD25 + ) cells ( Fig. 5L ) in the E16.5 2 0 6 mutant thymus compared to controls, suggesting a mild block at the DN3-DN4 transition. By late 2 0 7 fetal stages, the thymic structure had deteriorated beyond the ability to support any thymocyte 2 0 8 development. Thus, dysregulation of NOTCH signaling throughout the TEC compartment during fetal 2 1 0 development results in an abnormal TEC environment with an expanded mTEPC compartment, a 2 1 1 major block to mTEC differentiation, and eventually causes complete collapse of the epithelial 2 1 2 network. These data further support a role for NOTCH1 signaling in specifying the mTEPC pool 2 1 3 during fetal development. These data also suggest that while NOTCH1 must be present for 2 1 4 mTEPC specification, prolonged and/or excessive NOTCH1 signaling is detrimental to their 2 1 5 differentiation. Mosaic deletion of Notch1 shows that mTEC specification requires NOTCH signaling 2 1 8 Foxn1 Cre initiates Cre expression at E11.25 20 , very similar to the timing with which 2 1 9 mTEC specification may initiate 23 , and coincident with our expression data showing that active 2 2 0 NOTCH1 signaling in TECs in the developing thymus until E11.25 ( Fig. 1A ). Thus, it is possible 2 2 1 that the few mTECs that are present in the Foxn1 Cre ;Notch1 fx/fx mutant thymus underwent 2 2 2 specification prior to Notch1 deletion. Since Foxn1 Cre is also active throughout TEC 2 2 3 differentiation, these cells could have deleted Notch after mTEC specification; but since Notch 2 2 4 expression is dispensable for or even detrimental to mTEC differentiation, this later deletion 2 2 5 would have no effect. It would, however, make it impossible for us to determine whether this 2 2 6 scenario was correct, as we cannot determine whether Notch was deleted before or after mTEC 2 2 7 specification in these mTECs.
8
To test this possibility, we deleted Notch1 from throughout the pharyngeal endoderm 2 2 9
using Foxa2 CreER with a single pulse of tamoxifen at E8.5 24 , prior to the onset of Foxn1 2 3 0 expression 25 . We have previously shown that this single pulse of CRE activity produces a mosaic 2 3 1 deletion in the 3 rd pharyngeal pouch 26 , ideal for testing whether Notch1 deleted cells can 2 3 2 contribute to the mTEC lineage. Foxa2 CreER ;Notch1 fx/fx mice had fetal thymus phenotypes 2 3 3 consistent with those obtained using Foxn1 Cre , with reductions in both mTEC progenitor 2 3 4 numbers and medullary size (Figs. S1, S2). Using PCR primers that selectively amplified either 2 3 5 the undeleted or deleted allele, we performed qPCR on sorted cTEC and mTEC populations from deleted allele, which was completely absent in mTECs ( Fig. 6D ). These data strongly support the 2 4 2 conclusion that specification to the mTEC lineage requires NOTCH1 signaling, and is consistent with the idea that mTEC that are present in the Foxn1 Cre ;Notch1 fx/fx homozygous mutants had 2 4 4 specified to the mTEC lineage prior to Foxn1 expression. The Foxa2 CreER and Foxn1 Cre experiments support previous data showing that mTEC 2 4 8 begin to be specified quite early in thymus organogenesis, at around the time that Foxn1 is first 2 4 9 expressed, and that mTEC specification is Foxn1-independent 23 . To test the timing of Notch1 2 5 0 requirement in TECs across fetal development, we utilized a genetic system in which the 2 5 1 NOTCH pathway transcription factor RBPj is deleted in all TEC using Foxn1 Cre , and then the 2 5 2 capacity to respond to normal, physiological NOTCH signals is reactivated in a temporal and cell 2 5 3 type specific manner using doxycycline-controlled expression of transgenic RBPj-HA 2 5 4 (RBPj fx/fx ;Foxn1 Cre ;Rosa rtTA ;Tet on -RBPj-HA) 27 . Rbpj deletion using Foxn1 Cre resulted in similar 2 5 5 phenotypes at E16.5 and NB stages as Notch1 deletion, with many fewer mTEC, smaller 7B, E, H, and L panels) (see also companion paper, Liu et al.). We then temporally activated 2 5 8
Notch signaling responsiveness in TEC by providing doxycycline from E0-E14 (assayed at E16 2 5 9 and NB), or from E14-NB (assayed at NB). 7A', C'; 8E). Thus, just 2 days after withdrawing NOTCH responsiveness mTEC markers had 2 6 6 begun to decline. By the NB stage, UEA-1+ area and PLET1 intensity had begun to decline, and 2 6 7 UEA-1 intensity remained similar to E16.5 ( Fig. 7I , I', M'); these phenotypes were all improved 2 6 8 relative to uninduced RBPj mutants, but remained less than controls ( Fig. 8A, B , E). CLD3,4 2 6 9
staining remained similar to that seen at E16.5, and now were also similar to RBPj mutants, in signaling prior to E14 appears to be sufficient to establish an mTEC pool, but it fails to either 2 7 2 expand or be maintained properly after doxycycline withdrawal and removal of NOTCH In contrast, restoration of NOTCH signaling responsiveness beginning at E14 and 2 7 5 continuing until birth substantially restored medullary phenotypes at the NB stage. UEA-1, 2 7 6 CLD3,4, and PLET1 intensity were all similar to controls, and significantly increased relative to improved relative to uninduced and E0-14 injected samples ( Fig. 8C ). Furthermore, in both E0-2 8 0 14 and E14-NB samples, CLD3,4 and PLET-1 staining was largely non-overlapping, similar to 2 8 1 controls (Fig. S4 ), and distinct from the maintenance of overlapping staining seen in E16.5 2 8 2 Foxn1 Cre ;Notch1 fx/fx mutants (Fig. 2) , demonstrating that progression from PLET-1+CLD3,4+ to 2 8 3 expressing only one or the other marker is NOTCH1-dependent. These data suggest that NOTCH signaling is required not only for initial mTEC lineage 2 8 5 specification, but also for maintenance and/or expansion of the mTEC progenitors throughout 2 8 6 fetal stages. These data are also consistent with the possibility that mTEC progenitors can be 2 8 7 continue to be specified at later fetal stages. We used two NOTCH1 activity-trap mouse lines to trace the lineage of TECs 2 9 1 experiencing relatively high (N1IP::Cre LO ) or lower (N1IP::Cre HI ) levels of NOTCH1 2 9 2 activation 28 . In these two strains, the NOTCH1 intracellular domain was replaced with Cre, such 2 9 3 that NOTCH1 signaling triggers proteolytic cleavage and Cre is able to move to the nucleus. We 2 9 4 used these two strains to activate a CAG-tdTomato reporter 29 to permanently label cells 2 9 5 receiving a NOTCH1 signal and their progeny. Co-staining the resulting fetal thymi with TEC 2 9 6 markers allowed us to identify all TECs that arise from N1IP::Cre;tdTomato + cells through 2 9 7 ontogeny. Interestingly, we observed different patterns of NOTCH1 signaling lineage history in 2 9 8 the fetal thymus using these two lineage reporter lines (Figs. 9 and 10). TECs (N1IP::Cre LO ;tdTomato -) were Foxn1::EGFP + MHCII + (Fig. 9F ), confirming the TEC 3 1 1 identity of the cells. In terms of progenitors, CLD3,4 + cells expressed the N1IP::Cre LO ;tdTomato 3 1 2 reporter (yellow arrows, Fig. 9L,M) , whereas PLET1 + cells did not (white arrows in Fig 9H-J) . These data are consistent with our CBF:H2B-Venus reporter data (Fig. 1K,L) showing that the 3 1 4 mTEPC pool is undergoing active NOTCH signaling; these data specifically show that CLD3,4 + Next, we assessed the expression pattern of the N1IP::Cre HI ;tdTomato reporter in the 3 2 0 thymus at E14.5, which reports a broader range of NOTCH1 signaling (Fig. 10 ). Almost all 3 2 1 UEA1 + mTECs expressed the N1IP::Cre HI ;tdTomato reporter at E14.5 by IHC (cyan arrows in 3 2 2 Fig. 10C,D) and at the newborn stage by flow cytometric analysis (Fig. 10M ). Consistent with 3 2 3 our other expression, signaling, and lineage results, all CLD3,4 + cells were 3 2 4 N1IP::Cre HI ;tdTomato + (arrows in Fig. 10E-H) . However, in contrast to the results from the Analysis of this reporter in cTECs showed that some lineage-positive Foxn1::GFP + TECs 3 2 9 could also be detected in the cortex (white arrows in Fig. 10A-D) . Flow cytometry revealed that 3 3 0 around half of all cTECs (EpCam + UEA1 -) were tdTomato + at the newborn stage ( Fig. 10M) . (EpCam + UEA1 -N1IP::Cre HI tdTomato + ) were Foxn1::EGFP hi (Fig. 10M ). However, none of the 3 3 4 NOTCH1 lineage-negative cTECs expressed a high level of Foxn1::EGFP (Fig. 10M) . These Foxn1::EGFP low cells also had lower MHCII surface levels than the Foxn1::EGFP high cells the lower levels are also consistent with a less differentiated phenotype. Finally, to assess the level of current or recent as opposed to a history of NOTCH 3 4 0 1 3 signaling, we analyzed CBF:H2B-Venus expression at E16.5. While a substantial fraction of 3 4 1 mTECs and all CLD3,4 + mTECs were Venus + FOXN1 + , there were only rare Venus + FOXN1 + 3 4 2 cells in the cortex (Fig. 10N,O) . This result suggests the existence of two distinct populations of In summary, we have generated a fate map of NOTCH1 signaling during TEC ontogeny 3 4 6 using two NOTCH1 activity-trap mouse lines. Our data reveal that all mTECs, but only a subset 3 4 7 of cTECs, have experienced NOTCH1 signaling during fetal thymus development. current study, we provide evidence that NOTCH1 signaling is required to specify the lineage- results in an expansion of the TEPC pool, but then subsequent mTEC differentiation is also 3 6 0 blocked. These data indicate that NOTCH signaling is required for specification of mTEC 3 6 1 progenitors, and promotes their expansion, but that NOTCH signaling must cease for mTEC 3 6 2 differentiation to mature phenotypes to occur. The fact the removal of NOTCH signaling in TEC 3 6 3 after E14 results in progressive loss of the mTEC population also suggests that NOTCH 3 6 4 signaling is required for maintenance of mTEC progenitors, or for their proliferation. The is the major mediator of NOTCH signaling in TEC. A parallel study in the Blackburn lab targeting RBPj and thus globally affecting NOTCH signaling came to a similar conclusion (Liu, The developmental origins of separate cortical and medullary TEC lineages and the 3 7 0 existence and identity of bipotent TEC progenitors remains controversial. Whether they arise 3 7 1 1 4 from a common bipotent or individual lineage-restricted progenitors is still uncertain, with 3 7 2 evidence for both [11] [12] [13] [14] [15] [16] . Furthermore, it is still unclear exactly when and how the fetal and adult require different signals for specification. We identify NOTCH1 as a key molecule required for the establishment and expansion of 3 7 8 the mTEC progenitor pool. Our functional studies revealed that NOTCH1 pathway inhibition or have suggested that all TECs arise from a progenitor expressing cortical markers 13, 14 We propose a model in which NOTCH1 signaling is required to generate the mTEPC 3 9 0 pool during fetal thymus development (Fig. 11 ). Lineage restriction of these cells occurs 3 9 1 according to whether or not the bipotent progenitor itself, or its daughter cells, experience high 3 9 2 levels of NOTCH1 signaling. In this model, all TECs arise from a common bipotent progenitor 3 9 3 cell, although it is also formally possible that the PLET1 + CLD3,4 + TEPC population contains 3 9 4 separate cortical and medullary progenitors. Regardless, those cells that do receive a NOTCH1 3 9 5 signal will become PLET1 -CLD3,4 + mTEC lineage-restricted TEPCs; those that do not become is deleted from TECs (as in the Foxn1 Cre ;Notch1 fx/fx and Foxg1 Cre ;Notch1 fx/fx models presented pool is not generated. Our data also show that Notch1 must be down regulated for differentiation 4 0 0 of the PLET1 -CLD3,4 + cells into more mature mTECs, consistent with previous reports 7 . Thus, Our fate mapping lineage analysis showed that only half of fetal cTECs have experienced 4 0 4 NOTCH1 signaling, and that these cTECs have uniformly higher levels of Foxn1 and MHCII 4 0 5 expression than those that are NOTCH lineage-negative. These data indicate that NOTCH 4 0 6 signaling may also play a role in cTEC differentiation that is distinct from the mTEC role, NOTCH signaling (Fig. 9 ). Compared to mTECs, little is known about the cTEC lineage and its 4 0 9 development during ontogeny. As these two lineage-negative and lineage-positive populations 4 1 0 also differ in their levels of Foxn1 and MHCII expression, it is reasonable to conclude that these 4 1 1 populations may be distinct either in their level of maturity or their function. Although we did 4 1 2 not detect an obvious change in cTECs in our Notch1 deletion model, the relative lack of cTEC 4 1 3 markers means that we have little power to do so based on known markers. As a result, we can 4 1 4 only speculate at this point what the relationship between these two cTEC subsets may be. As the suggested that thymocytes are at least one source of ligand, and that an interaction between these 4 2 5 two cell types is required for TEC development 6 . In the current study, we first observed active 4 2 6 NOTCH1 signaling in Foxn1 + cells at early E11.5, which is coincident with the first wave of 4 2 7 lymphocyte entry to the primordium 30 , although it is clear in our data that TECs are not adjacent like4 5, 6, 30, 31 (Liu, et al, . Whether the specific ligands and their cellular source All mice and embryos were genotyped by PCR using DNA extracted from tail tissue. All experiments involving animals were performed with approval from the UGA For cryosectioning, mouse embryos were snap frozen in liquid nitrogen and stored at - Troma1), anti-K14 (Covance, AF64, 1:1,000) or UEA1 lectin (Vector Labs, X0922, 1:400). (PFA) in PBS for 5 min at 4°C, washed with PBS followed by 10% sucrose/PBS for 1 h, then were dehydrated through an ethanol series (70%, 80%, 90%, 96%, 100%) and embedded in 4 8 5 paraffin wax using standard procedures. Sections (8 μm) were cut and rinsed in xylene before 4 8 6 rehydration through a reverse ethanol series. Antigen retrieval was performed by boiling slides in 4 8 7 10 mM sodium citrate buffer, pH 6, for 30 min. Sections were stained using appropriate primary 4 8 8 and secondary antibodies as described above, and imaged using fluorescence microscopy. Hematoxylin and eosin (H&E) staining was performed on paraffin sections using analyzed using a CyAn ADP Flow Cytometer (Beckman Coulter, Miami, FL). Data were 5 0 0 collected using a four-decade log amplifier and stored in list mode for subsequent analysis using were stored in list mode for subsequent analysis using FlowJo Software.
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Cell isolation and genomic PCR 5 1 1 E15.5 thymi were harvested and processed individually to generate a single cell 5 1 2 suspension (as described above). TEC populations were isolated based on staining with PE-Cy7 5 1 3 conjugated anti-CD45, APC-conjugated anti-EpCam, UEA1 lectin and anti-MHCII as described 5 1 4
in the text. DNA was purified from sorted cell populations using QIAamp DNA Mini kit 5 1 5 (QIAGEN). PCR was performed using the following primer sequences: fwd-1 (undeleted 5 1 6 allele), TAC TTA GAG CGG GGC AGA GA; fwd-2 (deleted allele), CTG AGG CCT AGA 5 1 7 GCC TTG AA; rev (both deleted and undeleted alleles), ACT CCG ACA CCC AAT ACC TG. Data are presented as mean ± S.D. N values were at least 3 for each genotype in each
